Chicago, June 23, 2025 (GLOBE NEWSWIRE) -- The global amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, reflecting a ...
The FDA granted Fast Track designation to the investigational biologic combination therapy COYA 302 for amyotrophic lateral sclerosis treatment.
In a groundbreaking Canadian discovery powered by philanthropy, a team of Western University researchers led by Dr. Michael Strong has uncovered a potential path toward a cure for amyotrophic lateral ...
rocketcitynow.com on MSN
Crestwood ALS Clinic earns top honors for excellence in specialized patient care
Crestwood ALS Care Clinic is recognized as a Certified Treatment Center of Excellence by the ALS Association.
A research team at the Brain Research Institute, Niigata University has found that APOE ε4, a genetic factor best known for ...
Amyotrophic lateral sclerosis (ALS) is a rare motor neuron disorder. Currently, there is no cure for ALS and no treatment to stop or keep the disease from worsening over time. ALS mainly involves ...
“I am a person living with ALS,” the "Better Call Saul" actor revealed alongside his fiancée, Erica Tazel, on CNN’s "The ...
Celebrities including Russell Andrews and Eric Dane have fought ALS while inspiring others and advocating for research ...
Researchers have developed a technique that can identify errors caused by mutations linked to a range of genetic disorders, ...
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive, fatal neurological disorder, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results